Sugi Predict

Sugi Predict / Compounds / SCHEMBL1043487

SCHEMBL1043487

SCHEMBL1043487

COc1cc(Cl)ccc1C(=O)NC1CCC(Nc2cc(-c3c[nH]c4ncccc34)cc(Cl)n2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 19/20 0.62
▸ GSK3B P49841 10/20 0.62
▸ DYRK1A Q13627 11/20 0.55
▸ CLK1 P49759 1/20 0.55
▸ ROCK2 O75116 12/20 0.53
▸ PRKACA P17612 11/20 0.53
▸ CDK2 P24941 10/20 0.53
▸ HIPK2 Q9H2X6 10/20 0.53
▸ PIM1 P11309 9/20 0.53
▸ CDK9 P50750 8/20 0.53
▸ CDK7 P50613 5/20 0.53
▸ IRAK4 Q9NWZ3 4/20 0.53
▸ STK17A Q9UEE5 9/20 0.52
▸ MAP4K4 O95819 9/20 0.52
▸ CDK8 P49336 8/20 0.52
▸ CLK4 Q9HAZ1 8/20 0.52
▸ CLK2 P49760 8/20 0.52
▸ CDK5 Q00535 8/20 0.52
▸ DAPK3 O43293 7/20 0.52
▸ PRKX P51817 7/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1043488 1.00 CDC7 (0.62) CDC7GSK3BDYRK1ACLK1ROCK2
SCHEMBL1044819 0.85 CDC7 (0.67) CDC7GSK3BDYRK1AROCK2PRKACA
SCHEMBL1044817 0.85 CDC7 (0.67) CDC7GSK3BDYRK1AROCK2PRKACA
SCHEMBL1045903 0.84 CDC7 (0.64) CDC7GSK3BDYRK1AROCK2PRKACA
SCHEMBL1045904 0.84 CDC7 (0.64) CDC7GSK3BDYRK1AROCK2PRKACA
SCHEMBL1045476 0.84 CDC7 (0.74) CDC7GSK3BDYRK1AROCK2PRKACA
SCHEMBL1045823 0.83 CDC7 (0.72) CDC7GSK3BDYRK1AROCK2PRKACA
SCHEMBL1049821 0.83 CDC7 (0.72) CDC7GSK3BDYRK1AROCK2PRKACA
SCHEMBL1049823 0.83 CDC7 (0.72) CDC7GSK3BDYRK1AROCK2PRKACA
SCHEMBL1041849 0.82 CDC7 (0.68) CDC7GSK3BDYRK1AROCK2PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2454257-B1 PYRROLOPYRIDINE INHIBITORS OF KINASES ABBVIE INC (US) 2013-08-21 — — EP claimed
US-8435980-B2 Pyrrolopyridine inhibitors of kinases ABBVIE INC. (US) 2013-05-07 — — US claimed
EP-2454257-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES Abbott Laboratories (US) 2012-05-23 — — EP claimed
WO-2011008915-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2011-01-20 — — WO claimed
US-20110015173-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2011-01-20 — — US claimed
EP-2454257-B1 PYRROLOPYRIDINE INHIBITORS OF KINASES ABBVIE INC (US) 2013-08-21 — — EP disclosed
US-8435980-B2 Pyrrolopyridine inhibitors of kinases ABBVIE INC. (US) 2013-05-07 — — US disclosed
EP-2454257-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES Abbott Laboratories (US) 2012-05-23 — — EP disclosed
WO-2011008915-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2011-01-20 — — WO disclosed
US-20110015173-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2011-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015173-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES CDC7, MAP3K7, CDK1 CDC7 1/4885GSK3B 442/4885DYRK1A 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.